178 related articles for article (PubMed ID: 18190611)
1. The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease.
Yamada H; Watanabe M; Nanba T; Akamizu T; Iwatani Y
Clin Exp Immunol; 2008 Mar; 151(3):379-82. PubMed ID: 18190611
[TBL] [Abstract][Full Text] [Related]
2. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
3. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases.
Inoue Y; Watanabe M; Inoue N; Kagawa T; Shibutani S; Otsu H; Saeki M; Takuse Y; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):229-35. PubMed ID: 24990808
[TBL] [Abstract][Full Text] [Related]
4. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
5. IL-10 -592A/C polymorphism is associated with severity of Hashimoto's disease.
Inoue N; Watanabe M; Wada M; Morita M; Hidaka Y; Iwatani Y
Cytokine; 2013 Oct; 64(1):370-4. PubMed ID: 23757290
[TBL] [Abstract][Full Text] [Related]
6. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Ishido N; Katsumata Y; Kagawa T; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):262-9. PubMed ID: 25046415
[TBL] [Abstract][Full Text] [Related]
7. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
8. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
[TBL] [Abstract][Full Text] [Related]
9. Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene increases the risk of developing Graves' disease.
Doğru-Abbasoğlu S; Vural P; Baki M; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jun; 20(2):366-9. PubMed ID: 24742542
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease.
Morita M; Watanabe M; Inoue N; Inaoka C; Akamizu T; Tatsumi KI; Hidaka Y; Iwatani Y
Autoimmunity; 2012 Mar; 45(2):129-36. PubMed ID: 22014209
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
12. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
14. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T; Watanabe M; Inoue N; Arakawa Y; Tomari S; Hidaka Y; Iwatani Y
Autoimmunity; 2017 Sep; 50(6):386-392. PubMed ID: 28675712
[TBL] [Abstract][Full Text] [Related]
15. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.
Inoue N; Watanabe M; Nanba T; Wada M; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 May; 156(2):199-204. PubMed ID: 19250279
[TBL] [Abstract][Full Text] [Related]
16. Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells.
Hayashi F; Watanabe M; Nanba T; Inoue N; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 Dec; 158(3):281-6. PubMed ID: 19793334
[TBL] [Abstract][Full Text] [Related]
17. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
18. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease.
Sarumaru M; Watanabe M; Inoue N; Hisamoto Y; Morita E; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):329-37. PubMed ID: 27245255
[TBL] [Abstract][Full Text] [Related]
19. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
20. Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene suggests an association with increased risk for Hashimoto's thyroiditis.
Vural P; Değirmencioğlu S; Doğru-Abbasoğlu S; Baki M; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2015 Sep; 28(1):521-4. PubMed ID: 26218277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
